Meihua International Medical Technologies Co. Ltd. has announced a change in its stock market listing. The company has successfully transferred its shares from the Nasdaq Global Market to the Nasdaq Capital Market, effective June 6, 2025. This move has granted Meihua International an additional 180 days, until December 1, 2025, to meet the stock price requirements necessary to maintain its listing. The company is taking steps to address the situation and ensure compliance, with the potential of conducting a reverse stock split if needed to meet the standards.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.